The analysis incorporates manufacturing technology trends, clinical trial developments, regulatory approval pathways, and competitive positioning across therapeutic indications
Semaglutide GLP-1 lowers the chance of developing heart disease and some types of cancer, as well as other chronic diseases linked to obesity
This review reconsiders the debated concept of food addiction in light of these pharmacological advances, drawing on neurobiological, societal, and emerging clinical perspectives
These medications mimic a natural hormone to regulate appetite and promote fat loss
Just to back up for a second, eating (in general) triggers GLP-1 production
In the late 1980s, doctors were looking for new ways to treat diabetes, which affects millions of people